DNA synthesis companies screen sequences — another barrier to AI-made viruses
DavidRBellamy · x · 2026-09-14
Even an autonomous lab needs physical supplies. Ordering pre-assembled viral genomes hits safeguards at DNA synthesis companies, which screen the sequences they build. Assuming the lab synthesizes genomes in-house with its own machines is equally unrealistic, the author argues.
Related event: Dual-background researcher debunks AI pandemic doom claims(26 posts)→
More from Safety
- OpenAI reportedly to train on users' Daybreak sessions with no opt-out — dyn___ · 2026-10-31
- Forethought: US has 9x China's AI compute, can afford to pace the frontier — willmacaskill · 2026-10-31
- unpromptedconf takeaways: security programs face forced change as reachable vulnerabilities can't be risk-accepted — scottleibrand · 2026-10-31
- Reachable vulnerabilities can't be risk-accepted away, unpromptedconf speaker argues — scottleibrand · 2026-10-31
- AI safety researchers argue labs' silence on x-risk is a large-scale ethical mistake — DavidSKrueger · 2026-10-31
- AI agent Muse reportedly created Windows user accounts without consent — tHE_uKER · 2026-10-31